[Federal Register Volume 61, Number 234 (Wednesday, December 4, 1996)]
[Notices]
[Pages 64358-64359]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-30787]


-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institute of Allergy and Infectious Diseases; Notice of 
Meetings: National Advisory Allergy and Infectious Diseases Council; 
Acquired Immunodeficiency Syndrome Subcommittee; Allergy and Immunology 
Subcommittee; Microbiology and Infectious Diseases Subcommittee

    Pursuant to Pub. L. 92-463, notice is hereby given of the meeting 
of the National Advisory Allergy and Infectious Diseases Council, 
National Institute of Allergy and Infectious Diseases, and its 
subcommittees on January 23-24, 1997. Meetings of the Council, NAAIDC 
Allergy and Immunology Subcommittee, NAAIDC Microbiology and Infectious 
Diseases Subcommittee and the NAAIDC Acquired Immunodeficiency Syndrome 
Subcommittee will be held at the National Institutes of Health, 
Building 31C, Bethesda, Maryland.
    The meeting of the full Council will be open to the public on 
January 23 in Conference Room 10 from approximately 1 p.m. until 3:30 
p.m. for opening remarks of the Institute Director, discussion of 
procedural matters, Council business, and a report from the Institute 
Director which will include a discussion of budgetary matters. The 
primary program will include a discussion of the On-Line Review Pilot 
Program, an overview of reinvention and review issues being undertaken 
within the Division of Research Grants, and a presentation on emerging 
infectious diseases.
    On January 24 the meetings of the NAAIDC Allergy and Immunology 
Subcommittee and NAAIDC Microbiology and Infectious Diseases 
Subcommittee will be open to the public from 8:30 a.m. until 
adjournment. The subcommittees will meet in Building 31C, conference 
rooms 9 and 10 respectively.
    The meeting of the NAAIDC Acquired Immunodeficiency Syndrome 
Subcommittee will be open to the public from 8 until adjournment, on 
January 24. The subcommittee will meet in Conference Rooms E1/E2 at the 
Natcher Building.
    In accordance with the provisions set forth in secs. 552b(c)(4) and 
552b(c)(6), Title 5, U.S.C. and sec. 10(d) of Pub. L. 92-463, the 
meeting of the NAAIDC Acquired Immunodeficiency Syndrome Subcommittee, 
NAAIDC Allergy and Immunology Subcommittee and the NAAIDC Microbiology 
and Infectious Diseases Subcommittee will be closed to the public for 
approximately four hours for review, evaluation, and discussion of 
individual grant applications. It is anticipated that this will occur 
from 8:30 a.m. until approximately 1 p.m. on January 23, in conference 
rooms 8, 9 and 10 respectively. The meeting of the full Council will be 
closed from 4 p.m. until recess on January 23 for the review, 
discussion, and evaluation of individual grant applications. These 
applications and the discussions could reveal confidential trade 
secrets or commercial property such as patentable material, and 
personal information concerning individuals associated with the 
applications, disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.
    Ms. Claudia Goad, Committee Management Officer, National Institute 
of Allergy and Infectious Diseases, Solar Building, Room 3C26, National 
Institutes of Health, Bethesda, Maryland 20892, 301-496-7601, will 
provide a summary of the meeting and a roster of committee members upon 
request. Individuals who plan to attend and need special assistance, 
such as sign language interpretation or other reasonable 
accommodations, should contact Ms. Goad in advance of the meeting.
    Dr. Lawrence Deyton, Acting Director, Division of Extramural 
Activities, NIAID, NIH, Solar Building, Room 3C20, 6003 Executive 
Boulevard, Rockville, Maryland 20892, telephone 301-496-7291, will 
provide substantive program information.

(Catalog of Federal Domestic Assistance Program Nos. 93.855 
Immunology, Allergic and Immunologic Diseases Research, 93.856,

[[Page 64359]]

Microbiology and Infectious Diseases Research, National Institutes 
of Health)

    Dated: November 25, 1996.
Paula N. Hayes,
Acting Committee Management Officer, NIH.
[FR Doc. 96-30787 Filed 12-3-96; 8:45 am]
BILLING CODE 4140-01-M